Newsflash

Press Release – NEURO-BIO ATTRACTS OVER $3 MILLION IN SERIES A INVESTMENT TO DEVELOP A NEW APPROACH TO ALZHEIMER’S DISEASE Click here for the Neuro-Bio press release
Neuro-Bio
NB_build1
fac_slide
facilities_s2

Facilities

Neuro-Bio Ltd has 7,325 sq. ft, comprising of 3 labs, 6 offices and a meeting room.

We currently operate in three divisions:

  • Management
  • Biomarker
  • Drug Discovery

Techniques include:

  • Optical imaging with voltage-sensitive dyes.
  • Pharmacological manipulation on a range of cell lines in culture.
  • Molecular biology (ELISA and Western Blots) based on our proprietary antibodies.

To view a larger version of this map please Click Here